Positron Emission Tomography in Shy-Drager Syndrome
Ann Neurol 28:101-103, Bhatt,M.H.,et al, 1990
PET Study in Progressive Supranuclear Palsy, Hypometabolic Pattern
Arch Neurol 47:747-752, Blin,J.,et al, 1990
Positron Emission Tomography in Creutzfeldt-Jakob Disease
Arch Neurol 47:1035-1038, Holthodd,V.A.,et al, 1990
Transplantation of Human Fetal Dopamine Cells for Parkinson's Disease
Arch Neurol 47:505-512, Freed,C.R.,et al, 1990
National Cancer Institute Workshop Statement
Advances in Clinical Imaging Using Positron Emission Tomography, Arch Int Med 150:735-739, 729990., , 1990
Cerebral Metabolic Asymmetries & Assoc Neuro-psych Patterns in Early Dementia of the Alzheimer Type
Arch Neurol 47:753-760, Haxby,J.V., 1990
Infantile Spasms:I. PET Identified Focal Cortical Dysgenesis in Cryptogenic Cases for Surgical Treatment
Ann Neurol 27:406-413, Shields,W.D.,et al, 1990
Slowly Progressive Aphasia:Three Cases with Language, Memory, CT and PET Data
JNNP 53:987-993, Kempler,D.,et al, 1990
Pituitary Microadenomas:A PET Study
Radiology 177:39-44, DeSouza,B.,et al, 1990
The Brain in Schizophrenia
JNNP 53:725-726, Ron,M.A.&Harvey,I., 1990
The Evaluation and Treatment of Seizures
NEJM 323:1468-1474, Scheuer,M.L.&Pedley,T.A., 1990
PET Scanning, Provides Information on Function
BMJ 298:692-694, Frackowiak,R.S.J.&Jones,T., 1989
SPECT and PET in Epilepsy
Editorial, Lancet 1:135-1371989., , 1989
A Referendum on Clinical Trial Research in Multiple Sclerosis:Opinion of Jekyll Island Workshop
Neurol 39:977-981, Noseworthy,J.H.,et al, 1989
Immunological Treatment for Multiple Sclerosis
Editorial, Lancet 1:699-7011989., , 1989
Cerebral Glucose Metabolism in Wernicke's Broca's, and Conduction Aphasia
Arch Neurol 46:27-34, Metter,E.J.,et al, 1989
Cerebral Glucose Metabolism in the Course of Subacute Sclerosing Panencephalitis
Arch Neurol 46:97-100, Huber,M.,et al, 1989
Cyanide-Induced Parkinsonism:Clinical, MRI, and 6-Fluorodopa PET Studies
Neurol 39:142-144, Rosenberg,N.L.,et al, 1989
Normal-Pressure Hydrocephalus and the Saga of the Treatable Dementias
JAMA 262:2577-2581, 2592-25931989., Friedland,R.P., 1989
Positron Emission Tomography-A New Approach to Brain Chemistry
JAMA 260:2704-2710, Jacobson,H.G., 1988
Disconnection & Cerebral Metabolism, The Case of Conduction Aphasia
Arch Neurol 45:275-279, Kempler,D.,et al, 1988
Immunotherapy of Multiple Sclerosis
Ann Neurol 23:211-223, Weiner,H.L.&Hafler,D.A., 1988
Positron Emission Tomography in a Patient with Progressive Multifocal Leukoencephalopathy
Neurol 38:1864-1867, Kiyosawa,M.,et al, 1988
Brain Metabolism in Mitochondrial Encephalomyopathy:A PET Study
J Comput Assist Tomogr 12:854-857, DeVolder,A.,et al, 1988
Diagnosis & Treatment of Aphasia, Part I & Part II
JAMA 259:1043-1047, 1205-12101988., Albert,M.L.&Helm-Estabrooks,N., 1988
Cerebellar & Brainstem Hypometabolism in Olivo-pontocerebellar Atrophy Detected with Positron Emission Tomography
Ann Neurol 23:223-230, Gilman,S.,et al, 1988
Brain Glucose Metabolism in Thalamic Syndrome
JNNP 51:427-428, Laterre,E.C.,et al, 1988
Cerebral Hypometabolism in Progressive Supranuclear Palsy Studied with Positron Emission Tomography
Ann Neurol 24:399-406, Foster,N.L.,et al, 1988
Dementia in Down's Syndrome:Cerebral Glucose Utilization, Neuropsychological Assessment, and Neuropathology
Neurol 38:938-942, Schapiro,M.B.,et al, 1988
Surgical Treatment of Intractable Neonatal-Onset Seizures:The Role of Positron Emission Tomography
Neurol 38:1178-1188, Chugani,H.T.,et al, 1988
The Metabolic Pathology of the AIDS Dementia Complex
Ann Neurol 22:700-706, Rottenberg,D.A.,et al, 1987
Normal Caudate Glucose Metabolism in Persons at Risk for Huntington's Disease
Arch Neurol 44:254-257, Young,A.B.,et al, 1987
The Lennox-Gastaut Syndrome:Metabolic Subtypes Determined by FDG Positron Emission Tomography
Ann Neurol 21:4-13, Chugani,H.T.,et al, 1987
Cerebral Glucose Metabolism in the Lennox-Gastaut Syndrome
Ann Neurol 21:14-21, Theodore,W.H.,et al, 1987
Primary Progressive Aphasia-Differentiation from Alzheimer's Disease
Ann Neurol 22:533-534, Mesulam,M.M., 1987
The Combined Use of Positron Emission Tomography & DNA Polymorphisms for Preclinical Detection of Huntington's Disease
Neurol 37:1441-1447, Hayden,M.R.,et al, 1987
Wilson's Disease Studies with FDG & Positron Emission Tomography
Neurol 37:1707-1711, Hawkins,R.A.,et al, 1987
Total Lymphoid Irradiation in Multiple Sclerosis:Blood Lymphocytes & Clinical Course
Ann Neurol 22:634-638, Cook,S.D.,et al, 1987
Metabolic & Clinical Correlates of Acute Ischemic Infarction
Neurol 37:1103-1110, Kushner,M.,et al, 1987
Positron Emission Tomography Studies of Cerebral Glucose Metabolism in Chronic Partial Epilepsy
Ann Neurol 22:480-486, Abou-Khalil,B.W.,et al, 1987
Borderzone Ischemia
Ann Neurol 22:707-713, Leblanc,R.,et al, 1987
Differences in Cerebral Blood Flow & Glucose Utilization in Vegetative Versus Locked-in Patients
Ann Neurol 22:673-682, Levy,D.E.,et al, 1987
Effect of Total Lymphoid Irradiation in Chronic Progressive Multiple Sclerosis
Lancet 1:1405-1409, Cook,S.D.,et al, 1986
Alzheimer's Disease
NEJM 314:964-973, Katzman,R., 1986
Comparison of PET, MRI, & CT with Pathology in a Proven Case of Alzheimer's Disease
Neurol 36:1569-1574, McGeer,P.L.,et al, 1986
PET, CT, & MR Imaging in Cerebrovascular Disease
J Comput Assist Tomogr 10:903-911, Heiss,W.D.,et al, 1986
Alzheimer's Disease & Down's Syndrome:New Insights
Ann Int Med 103:566-578, Cutler,N.R.,et al, 1985
Positron Emission Tomography & its Application to the Study of Cerebrovascular Disease in Man
Stroke 16:361-376, Powers,W.J.,et al, 1985
Pure Hemidystonia with Basal Ganglion Abnormalities on Positron Emission Tomography
Ann Neurol 15:228-233, Perlmutter,J.S.,et al, 1984
Parkinson's Disease, 1984
Lancet 1:829-830, Williams,D.,et al, 1984